AN OVERVIEW OF THERAPEUTIC POTENTIAL OF THYMOQUINONE

被引:5
作者
Agarwal, Swati [1 ]
Srivastava, Rashmi [1 ]
Mishra, Neetu [2 ]
机构
[1] Univ Allahabad, Ctr Food Technol, Allahabad 211002, Uttar Pradesh, India
[2] Univ Allahabad, Dept Home Sci, Allahabad 211002, Uttar Pradesh, India
来源
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH | 2019年 / 10卷 / 08期
关键词
Thymoquinone; Nigella sativa; Therapeutic potential; Anti-oxidant; Anti-microbial; Anti-inflammatory; NIGELLA-SATIVA OIL; OXIDATIVE STRESS; CELLS; CONSTITUENT; ATHEROSCLEROSIS; 5-LIPOXYGENASE; OSTEOSARCOMA; ATTENUATION; APOPTOSIS; MOLECULE;
D O I
10.13040/IJPSR.0975-8232.10(8).3532-39
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Herbal medication has attracted much attention in recent years and is being used as an alternative to chemical medicines. Some evidence supports the positive effects of medicinal plants in the prevention and treatment of different types of diseases. Thymoquinone (TQ) is the most abundant component of Nigella sativa seeds, and most of the properties of Nigella sativa are attributed primarily to TQ. It belongs to a class of naturally presenting phenols, chemically known as 2-isopropyl-5-methyl benzo-1, 4-quinone (C10H12O2), is a dark yellow crystalline monoterpene diketone, abundantly found in the seeds of Nigella sativa. Besides Nigella sativa, TQ is an active ingredient of several plants as Juniperus, Monarda, Coridothymus, Agastache, Satureja. It has been reported to possess various beneficial therapeutic effects including anti-oxidant, anti-inflammatory, anti-microbial, anti-diabetic, hepato-protective and cardioprotective effects. It is significant to say that TQ may be effective as a powerful contender of natural origin with therapeutic potential against an array of maladies.
引用
收藏
页码:3532 / 3539
页数:8
相关论文
共 59 条
[1]   The Effect of Route of Administration in Thymoquinone Toxicity in Male and Female Rats [J].
AbuKhader, M. M. .
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 74 (03) :195-200
[2]  
Adewoye E O, 2015, Afr J Med Med Sci, V44, P261
[3]   Prognostic Determinants of Coronary Atherosclerosis in Stable Ischemic Heart Disease Anatomy, Physiology, or Morphology? [J].
Ahmadi, Amir ;
Stone, Gregg W. ;
Leipsic, Jonathon ;
Shaw, Leslee J. ;
Villines, Todd C. ;
Kern, Morton J. ;
Hecht, Harvey ;
Erlinge, David ;
Ben-Yehuda, Ori ;
Maehara, Akiko ;
Arbustini, Eloisa ;
Serruys, Patrick ;
Garcia-Garcia, Hector M. ;
Narula, Jagat .
CIRCULATION RESEARCH, 2016, 119 (02) :317-329
[4]   The effect of thymoquinone on intractable pediatric seizures (pilot study) [J].
Akhondian, Javad ;
Kianifar, Hamidreza ;
Raoofziaee, Mohammad ;
Moayedpour, Amir ;
Toosi, Mehran Beiraghi ;
Khajedaluee, Mohammad .
EPILEPSY RESEARCH, 2011, 93 (01) :39-43
[5]   Nigella Sativa and Thymoquinone Suppress Cyclooxygenase-2 and Oxidative Stress in Pancreatic Tissue of Streptozotocin-Induced Diabetic Rats [J].
Al Wafai, Rana J. .
PANCREAS, 2013, 42 (05) :841-849
[6]   Potential Protective Effects of Nigella Sativa and Allium Sativum Against Fructose-Induced Metabolic Syndrome in Rats [J].
Al-Rasheed, Nawal ;
Al-Rasheed, Nouf ;
Bassiouni, Yieldez ;
Faddah, Laila ;
Mohamad, Azza M. .
JOURNAL OF OLEO SCIENCE, 2014, 63 (08) :839-848
[7]   RETRACTED: Protective and antidiabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluation(Retracted article. See vol. 11, 2016) [J].
Alimohammadi, Samad ;
Hobbenaghi, Rahim ;
Javanbakht, Javad ;
Kheradmand, Danial ;
Mortezaee, Reza ;
Tavakoli, Maryam ;
Khadivar, Farshid ;
Akbari, Hamid .
DIAGNOSTIC PATHOLOGY, 2013, 8
[8]   Black Cumin (Nigella sativa) and Its Active Constituent, Thymoquinone: An Overview on the Analgesic and Anti-inflammatory Effects [J].
Amin, Bahareh ;
Hosseinzadeh, Hossein .
PLANTA MEDICA, 2016, 82 (1-2) :8-16
[9]   Comparative evaluation of anti-inflammatory properties of thymoquinone and curcumin using an asthmatic murine model [J].
Ammar, El-Sayed M. ;
Gameil, Nariman M. ;
Shawky, Noha M. ;
Nader, Manar A. .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (12) :2232-2236
[10]  
[Anonymous], EVID BASED COMPLEMEN